Comments by CABF Research Policy Director, Martha
Hellander at American Academy of Child & Adolescent Psychiatry, Town
Meeting, Washington, DC. (AACAP 2004 Annual Meeting)
October 21, 2004
Hello, and thank you for inviting me today. I should start by saying that I
have no conflicts of interest other than being a mom. I am also the Research
Policy Director and co-founder of the Child & Adolescent Bipolar Foundation,
a nonprofit advocacy group of nearly 25,000 families
raising children diagnosed
with, or at risk for, bipolar disorder. Over half of our children are under the
age of 12, more than half of them have been hospitalized anywhere from 1 to 10
times, and about a third of them take
antidepressants along with mood
stabilizers. Many of our members reported in an informal poll last January, as
we testified before the FDA, that their children had been
suicidal from a very
young age, often before taking any medications; others were never observed by
their parents to be suicidal until soon after taking antidepressants, and among
those families, about half report that the suicidal behavior stopped when the
medication was removed.
CABF does not take a position on whether individual cases were or were not
caused by antidepressants. Our position is that mood disorders in children are a
major public health crisis, and antidepressants are an essential part of
treatment for SOME, but not all, of those kids. CABF welcomes the FDA attention,
and increased warnings, being added to the labeling of these medications. As we
say at CABF, these are powerful and potentially dangerous drugs that are used of
necessity to treat powerful and extremely dangerous illnesses.
Doctors and parents must keep in mind that symptoms of depression in a child
may not be a one-time episode, but a manifestation of a developmental stage of a
lifelong, hereditary illness such as bipolar disorder–in which more time is
typically spent depressed than manic–or schizophrenia. Parents need to know that
depression is often the first sign of bipolar disorder, and is also the most
common symptom seen in adolescents during the five years prior to the first
psychotic break in schizophrenia. So how can we tell which kid presenting with
depression is likely to respond well, or have an adverse reaction to, a
particular medication? We can’t at this time. We can recognize depression in
even preschoolers now, but we don’t yet know how to match up which kids with
which treatments.
To parents demanding an answer, and God knows how badly we want answers, you
must stand firm and say "I don’t know." We need you to be honest and tell us
frankly that if you conclude that our children are depressed, you have no way of
telling whether it is the type of depression likely to respond to an
antidepressant, or to psychotherapy, or whether the medication might provoke the
child to become manic, or go into a mixed state (which is the highest period of
risk for suicide in those with bipolar disorder). And until we have a major
federal investment into research on these questions, you will have no answers.
To quote the Dali Lama, "Wisdom is the ability to tolerate ambiguity." In other
words, don’t give us false assurances.
Many parents aren’t going to like this ambiguity, of course. They want you to
reassure them that it is probably nothing serious, that you’re confident the
child will grow out of it, and they will look back in a couple of years and
laugh at how worried they are now. Please do not sugar-coat the implications of
depression in a child. You must deliver the bad news, unvarnished, and lay out
the worst case scenario, as well as the best case scenario, and admit to parents
that you don’t know whether this or that treatment will help the child. It is
essential that parents hear from you, and from advocacy groups such as CABF,
that suicide is a possible outcome of depression itself in children. This fact
is not widely known, and until it is, the public will continue to assume that
suicides that occur while a patient is on antidepressants were caused by the
drug. Large clinical trials were not designed to tell, in individual cases, what
happened. Large group statistics do not identify the lives lost, or the lives
saved, at an individual level.
Screen the child for mania. Use the Young Mania Rating Scale–Parent
Version on our web site; a group led by Mani Pavuluri is presenting a child
mania rating scale at this conference on Saturday afternoon. CABF will encourage
parents to do this screening at home, so you may find parents coming in more
educated than before. This is good. Parents ignorant of the symptoms of mania
will not call manic behaviors to your attention unless you ask; we tend to be
proud of our young kids who stay up late writing poetry, or plays, or making art
projects, and admire their bravery and adventuresome nature as they climb to the
top of the tallest tree or go fearlessly headfirst down the slide over and over
again. We are not likely to mention that our kids rarely sleep at night, or
won’t stop talking from morning until night, unless you ask us.
Take a family history. You may discover that this child’s family, on
both sides, has many individuals with bipolar illness or schizophrenia. Educate
parents as to why it might make sense to starting a depressed child with some
manic tendencies and a family history of bipolar disorder on one of the mood
stabilizers known to reduce the risk of suicide, such as lithium, before
starting the child on an antidepressant.
Monitoring. This is the latest intervention to prevent suicide by
children on antidepressants that has taken the country by storm–it is called
"monitoring." Is there evidence about how effective it is, of what it consists?
In what environment? Is the concept of monitoring likely to induce a false sense
of security?
I have asked several parents whose children took their lives what sort of
"monitoring" might have saved them. I was told about the teenage boy just out of
the hospital whose parents pleaded with the doctor and insurance company to keep
him over the weekend. He was started on medication, discharged over their
objections, and told by the doctor to just "go home and have a low-key weekend"
and report for day hospital on Monday. They made it through Friday night, and
Saturday, and Saturday night, one or the other of them always by his side, even
sleeping with him at night. Come Sunday, the father had to run an errand, and
the mother needed to use the bathroom. During a few moments alone, the boy stole
the car keys and the car, disabled the family phone, and drove off to end his
life. Does this mean that during monitoring, parents should not leave the house
to buy food, or go to the bathroom? And how many adults must be present; what
options are there for single parents, or with other young children to care for,
or working parents?
Another mom told me that her daughter got into the medicine cabinet in the
family bathroom, and took all the aspirin and Tylenol she could find. The doctor
treating her child had not told her to "suicide proof" the house, had not, in
fact, told her at all that a depressed child may attempt suicide. Had she known,
she told me, she would have locked up the medicine cabinet. Must the house be
"suicide-proofed?" I question whether this is even possible, unless one puts
grates over windows, removes closet rods and belts, and locks the doors with
deadbolt locks from the inside.
Other parents have told me of how in a moment when their back was turned,
their depressed children took kitchen knives and cut their wrists, or got up in
the middle of the night when the parents were sleeping, wandering the house to
find objects with which to
injure themselves. During monitoring, are parents to
stay awake round-the-clock? Perhaps "monitoring," to be adequate, means constant
supervision, literally round the clock, in a secure environment (so the child
cannot run off and head for the railroad tracks to throw himself in front of a
train, as one boy did), and in which the cupboards, drawers, utensils,
doorknobs, indeed, any object, substance, or opportunity by which to harm
themselves or attempt suicide has been removed. I don’t know of any such place,
except for a locked inpatient hospital unit or locked residential treatment
center. What are the implications of that, when insurance companies refuse to
cover hospital or residential treatment for so-called "mental" illnesses beyond
a few days, and even there, hospitals often use one-on-one continuous
observation or check patients every 15 minutes, with round-the-clock staffing.
So there is a huge need for some guidance to parents of what exactly does
"monitoring" mean for them, and we question whether it is really possible for
most families to do it at home.
I want to thank each of you for devoting your careers to studying and healing
a particularly painful type of suffering endured by too many children. As times
change and we learn more about the brain and how it is molded both by genes and
environment, we look to you to identify the illness that is attacking their
brains and destroying their will to live and sometimes ending their lives. We
look to you to provide healing treatment and advice to help us return them to a
normal path of development. It seems ironic that at a time when your services
are in such great demand, with your appointment books filled for months into the
future, that you are often portrayed in the media as carelessly eager to drug
America’s children. That’s just not true. Please don’t be discouraged. We
parents whose children’s lives have been saved by modern medicine and
appropriate psychotherapy wisely administered are grateful to you, and to your
colleagues who do the research, and to those who develop and produce medication
and other treatments.
We need to stand together and insist upon more federal funding and investment
in research on these important questions.
Thank you.
Martha Hellander CABF Research Policy Director October 21, 2004
top ~
next ~
send page to a
friend |